The scientist’s investigation covers issues in Internal medicine, Endocrinology, Glucagon-like peptide-1, Incretin and Insulin. Her Internal medicine research includes elements of Diabetes mellitus, Type 2 diabetes and Dipeptidyl peptidase. She interconnects Vildagliptin and Enzyme inhibitor in the investigation of issues within Dipeptidyl peptidase.
In her study, which falls under the umbrella issue of Endocrinology, Creatinine and Renal function is strongly linked to Pharmacokinetics. Her Glucagon-like peptide-1 research incorporates elements of Liraglutide, Gastric emptying, Impaired glucose tolerance, Glycemic and Biological activity. Carolyn F. Deacon combines subjects such as Sitagliptin, Enzyme, Hormone, Pharmacology and Dipeptidyl peptidase-4 with her study of Incretin.
Her scientific interests lie mostly in Internal medicine, Endocrinology, Glucagon-like peptide-1, Incretin and Type 2 diabetes. Her Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Dipeptidyl peptidase and Dipeptidyl peptidase-4. Her work in Insulin, Postprandial, Hormone, Gastric inhibitory polypeptide and Glucagon secretion is related to Endocrinology.
As a part of the same scientific study, Carolyn F. Deacon usually deals with the Glucagon-like peptide-1, concentrating on Peptide and frequently concerns with Amide and Radioimmunoassay. Her studies deal with areas such as Meal, Enteroendocrine cell and Glucose homeostasis, Insulin resistance as well as Incretin. She has researched Type 2 diabetes in several fields, including Metformin and Islet.
Her main research concerns Internal medicine, Endocrinology, Glucagon-like peptide-1, Glucagon and Incretin. Her studies in Internal medicine integrate themes in fields like Diabetes mellitus, Type 2 diabetes and Dipeptidyl peptidase-4. She regularly ties together related areas like Receptor in her Endocrinology studies.
Her Glucagon-like peptide-1 research includes themes of Vildagliptin, Gastric inhibitory polypeptide, Central nervous system, Metabolite and Chocolate milk. Her work carried out in the field of Glucagon brings together such families of science as Cholecystokinin, Glucose clamp technique and Glycogenolysis. Her Incretin research is multidisciplinary, incorporating elements of Paracrine signalling, Hormone, Insulin resistance, Glucose homeostasis and Pancreatitis.
Carolyn F. Deacon focuses on Endocrinology, Internal medicine, Glucagon-like peptide-1, Incretin and Glucagon. Her Glucagon secretion, Insulin, Secretion and Pancreatic polypeptide study, which is part of a larger body of work in Endocrinology, is frequently linked to Peptide YY, bridging the gap between disciplines. Carolyn F. Deacon has included themes like Neprilysin, Candoxatril and Chocolate milk in her Internal medicine study.
Her Glucagon-like peptide-1 research is multidisciplinary, relying on both Weight loss, Gastric inhibitory polypeptide, Central nervous system, Postprandial and Appetite. Her work deals with themes such as Metformin, Hormone, Paracrine signalling and Glucose homeostasis, which intersect with Incretin. Her Glucagon study deals with Glucose clamp technique intersecting with Radioimmunoassay and Endogeny.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
Tina Vilsbøll;Thure Krarup;Carolyn F. Deacon;Sten Madsbad.
Diabetes (2001)
Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects
Carolyn F Deacon;Michael A Nauck;Maibritt Toft-Nielsen;Lone Pridal.
Diabetes (1995)
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo
C F Deacon;A H Johnsen;J J Holst.
The Journal of Clinical Endocrinology and Metabolism (1995)
Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine.
Lene Hansen;Carolyn F. Deacon;Cathrine Ørskov;Jens J. Holst.
Endocrinology (1999)
Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
Jens J. Holst;Carolyn F. Deacon.
Diabetes (1998)
Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes
Gary A. Herman;Arthur Bergman;Catherine Stevens;Paul Kotey.
The Journal of Clinical Endocrinology and Metabolism (2006)
Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.
Carolyn F. Deacon;Michael A. Nauck;Juris Meier;Katrin Hücking.
The Journal of Clinical Endocrinology and Metabolism (2000)
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon.
Diabetes, Obesity and Metabolism (2011)
The incretin system and its role in type 2 diabetes mellitus.
Jens Juul Holst;Tina Vilsbøll;Carolyn F. Deacon.
Molecular and Cellular Endocrinology (2009)
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
C F Deacon;T E Hughes;J J Holst.
Diabetes (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Copenhagen
Copenhagen University Hospital
University of Copenhagen
Ruhr University Bochum
Lund University
Ruhr University Bochum
University of Adelaide
University of Copenhagen
Max Planck Institute of Biochemistry
University of Copenhagen
Mines ParisTech
University of Electronic Science and Technology of China
Xiamen University
Waseda University
University of Southern Denmark
Cornell University
Washington State University
Federal University of Toulouse Midi-Pyrénées
Norwegian University of Life Sciences
Indian Institute of Science Bangalore
Hokkaido University
Complutense University of Madrid
International Centre for Integrated Mountain Development
National Oceanic and Atmospheric Administration
University of Delaware
Centre national de la recherche scientifique, CNRS